Search
Tuberculosis Programme
The Tuberculosis Programme supports EU Member States in all aspects of tuberculosis (TB) prevention and control.
European Reference Laboratory Network for TB (ERLTB-Net)
The ERLTB-Net sub-network of reference laboratories from EU/EEA Member States supports harmonisation of methods and laboratory capacity for tuberculosis diagnosis, antimicrobial susceptibility testing and typing in the EU/EEA.
News
Drug-resistant Tuberculosis continues to spread: new report. Concern about childhood TBArchived
A new report, Tuberculosis surveillance in Europe 2009, a joint publication from ECDC and the WHO Regional Office for Europe to mark World Tuberculosis Day 2011, provides evidence for concern about the spread of multi-drug resistant tuberculosis (MDR TB) and the persistence of TB among children.
Antimicrobial resistance - Tuberculosis
In EU, only 1 in every 3 MDR TB patients has a successful treatment outcome; more than half either die, fail treatment or default (stop taking treatment). XDR TB has even worse treatment outcomes: only 1 in 4 patients finishes treatment successfully.
Data
Key messages - Drug-resistant tuberculosis
TB is slowly declining but MDR and XDR TB pose a serious challenge in the attempt to eliminate TB across Europe.
News
Every hour 30 people are diagnosed with tuberculosis in the European Region. It’s time to make TB a disease of the past
The latest ECDC/WHO report Tuberculosis surveillance and monitoring in Europe 2019 (2017 data) shows that despite an overall decline in numbers of people suffering from TB, the disease remains a major public health challenge in the Region.
Peer-Reviewed Publication
External quality assessment for tuberculosis diagnosis and drug resistance in the European union: A five year multicentre implementation study
Nikolayevskyy, V., Hillemann, D., Richter, E., Ahmed, N., Van Der Werf, M.J., Kodmon, C., Drobniewski, F., Ruesch-Gerdes, S.
Peer-Reviewed Publication
Childhood multidrug-resistant tuberculosis in the European union and European economic area: An analysis of tuberculosis surveillance data from 2007 to 2015
Ködmön, C., van den Boom, M., Zucs, P., van der Werf, M.J.
Peer-Reviewed Publication
Cross-border outbreak of extensively drug-resistant tuberculosis linked to a university in Romania
Popovici, O., Monk, P., Chemtob, D., Chiotan, D., Freidlin, P.J., Groenheit, R., Haanperä, M., Homorodean, D., Mansjö, M., Robinson, E., Rorman, E., Smith, G., Soini, H., Van Der Werf, M.J.
Peer-Reviewed Publication
ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update
Migliori,G.B., Sotgiu,G., Rosales-Klintz, S., Centis, R., D'Ambrosio, L., Abubakar, I., Bothamley, G., Caminero, J. A., Cirillo, D.M., Dara, M., de Vries, G., Aliberti, S., Dinh-Xuan, A.T., Duarte, R., Midulla, F., Solovic, I., Subotic, D.R., Amicosante, M., Correia, A.M., Cirule, A., Gualano, G., Kunst, H., Palmieri, F., Riekstina, V., Tiberi, S., Verduin, R., van der Werf, M.J.